MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 56 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282,342 | -29.2% | 218,870 | -27.5% | 0.00% | – |
| Q2 2023 | $398,508 | +637.6% | 301,900 | +295.7% | 0.00% | – |
| Q1 2023 | $54,031 | +449.9% | 76,289 | +482.4% | 0.00% | – |
| Q4 2022 | $9,825 | -93.9% | 13,100 | -93.0% | 0.00% | – |
| Q3 2022 | $161,000 | -27.1% | 186,625 | -5.4% | 0.00% | – |
| Q2 2022 | $221,000 | +325.0% | 197,179 | +326.8% | 0.00% | – |
| Q1 2022 | $52,000 | -82.3% | 46,200 | -74.8% | 0.00% | – |
| Q4 2021 | $294,000 | -27.4% | 183,274 | +9.5% | 0.00% | – |
| Q3 2021 | $405,000 | -13.8% | 167,382 | +12.9% | 0.00% | – |
| Q2 2021 | $470,000 | -28.6% | 148,229 | -24.0% | 0.00% | – |
| Q1 2021 | $658,000 | – | 195,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
| Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
| DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
| J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
| Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
| HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
| F3Logic, LLC | 255 | $668,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
| CSS LLC/IL | 54,773 | $144,000 | 0.01% |